Epidemiology of idiopathic cardiomyopathy in Japan: results from a nationwide survey

Abstract

Objective: To estimate the total number of patients with idiopathic cardiomyopathy in Japan and the prevalence of the disorder. Design: A nationwide epidemiological survey. Setting: Hospitals selected randomly from among all hospitals in Japan. Patients: Patients presenting with any of the three types of idiopathic cardiomyopathy: dilated cardiomyopathy, hypertrophic cardiomyopathy, and restrictive cardiomyopathy. Main outcome measures: The total number of patients in Japan was estimated using the sampling and response rates in each stratum with respect to hospital size. The second survey was conducted for patients reported in the first survey in order to obtain detailed information, including age, sex, and specific clinical data. Results: Estimated patient totals and 95% confidence intervals (CI) were 17 700 (95% CI 16 500 to 18 800) for dilated cardiomyopathy, 21 900 (95% CI 20 600 to 23 200) for hypertrophic cardiomyopathy, and 300 (95% CI 250 to 350) for restrictive cardiomyopathy. Crude prevalence per 100 000 population was estimated as 14.0 for dilated cardiomyopathy, 17.3 for hypertrophic cardiomyopathy, and 0.2 for restrictive cardiomyopathy; crude incidence per 100 000 person-years was estimated as 3.58, 4.14, and 0.06, respectively. Conclusions: The total number and prevalence of patients with idiopathic cardiomyopathy in Japan are estimated for the first time in a nationwide survey. The prevalence of dilated cardiomyopathy in Japan appears to be about half that of Western populations, while that of hypertrophic cardiomyopathy is about the same.

Clinical Impact of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy Results From Kochi RYOMA Study

“…Our regional cohort in the Kochi RYOMA study was older than HCM cohorts in previous studies, [7][8][9][10][11]18 probably because Kochi Prefecture, where our study was performed, is located far from urban areas and is one of the most aged communities in Japan. The percentage of male patients in our cohort (64%) was similar to the percentages in previous studies in Western countries and Japan.…”

Myosin binding protein C: Structural abnormalities in familial hypertrophic cardiomyopathy

“…Indeed FHC is the most common cause of sudden cardiac death in young athletes [21]. The prevalence of FHC is believed to be about 0.2%, or 1 in 500 [22,23]. However despite its relatively high prevalence, the mortality rate for FHC-related deaths in an unselected population was estimated to be only 1% [24].…”

Epidemiology and genetics of hypertrophic cardiomyopathy

“…The Our study showed an increased preponderance of the condition among the males (78.7%) when compared to females (21.3%), with the sex ratio being 3.7:1, which indicates a higher male preponderance compared to previous studies from western (2.9:1) and Japanese (2.3:1) populations. [11,12] The sex ratio in the different subsets of HCM were found to be 3. In general 31% of the HCM probands have a familial history of the disease, which is in conformation with other reports.…”